Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2018

01-09-2018 | Original Research

Partners and Alerts in Medication Adherence: A Randomized Clinical Trial

Authors: Judd B. Kessler, PhD, Andrea B. Troxel, ScD, David A. Asch, MD, MBA, Shivan J. Mehta, MD, MBA, MSHP, Noora Marcus, MA, Raymond Lim, MA, Jingsan Zhu, MS, MBA, William Shrank, MD, MSHS, Troyen Brennan, MD, Kevin G. Volpp, MD, PhD

Published in: Journal of General Internal Medicine | Issue 9/2018

Login to get access

Abstract

Background

Poor medication adherence is common and limits the effectiveness of treatment.

Objective

To investigate how social supports, automated alerts, and their combination improve medication adherence.

Design

Four-arm, randomized clinical trial with a 6-month intervention.

Participants

A total of 179 CVS health employees or adult dependents with CVS Caremark prescription coverage, a current daily statin prescription, a medication possession ratio less than 80%, and Internet access.

Interventions

Participants were randomly assigned to control, social support (partner), automated adherence alert messages (alert), or both social support and alerts (partner + alert). Participants in the social support arms were asked to name a medication adherence partner (MAP) to help them take their medication. Participants in the alert arms were sent emails, text messages, or automated phone calls if they had failed to adhere on the previous day and on one or both of the 2 days before that. In partner + alert, both participants and fully enrolled MAPs received alerts.

Main Measures

Adherence measured by wireless pill bottle opening.

Key Results

Compared to 36.0% adherence in control, adherence was significantly greater in the alert arm (52.9%, difference vs. control of 17.0%, 95% CI for difference 6.3 to 27.6%, P = 0.002) and the partner + alert arm (54.5%, difference vs. control of 18.6%, 95% CI for difference 6.6 to 30.5%, P = 0.003). Adherence in the partner arm was not statistically significantly greater than control (43.2%, difference vs. control of 7.2%, 95% CI of difference − 5.2% to 19.5%, P = 0.25). There were no statistically significant differences among the three treatment arms. Fewer participants invited a MAP in the partner + alert arm than the partner arm (P = 0.02).

Conclusions

Automated alerts were effective at improving medication adherence. Assigning a medication adherence partner did not statistically significantly affect adherence rates.

Trial Registration

Literature
1.
go back to reference Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78.CrossRefPubMed Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78.CrossRefPubMed
2.
go back to reference Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–9 Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–9
3.
go back to reference Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. New England Journal of Medicine 2004;350:1495–504.CrossRefPubMed Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. New England Journal of Medicine 2004;350:1495–504.CrossRefPubMed
4.
go back to reference Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462–7.CrossRefPubMed Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462–7.CrossRefPubMed
5.
go back to reference Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842–7.CrossRefPubMed Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842–7.CrossRefPubMed
6.
go back to reference Hudson M, Richard H, Pilote L. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap? Pharmacoepidemiol Drug Saf 2007;16:773–85.CrossRefPubMed Hudson M, Richard H, Pilote L. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap? Pharmacoepidemiol Drug Saf 2007;16:773–85.CrossRefPubMed
7.
go back to reference Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. Jama 2007;297:177–86.CrossRefPubMed Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. Jama 2007;297:177–86.CrossRefPubMed
8.
go back to reference Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. The Canadian journal of cardiology 2005;21:485–8.PubMed Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. The Canadian journal of cardiology 2005;21:485–8.PubMed
9.
go back to reference Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 2002;88:229–33.CrossRefPubMedPubMedCentral Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 2002;88:229–33.CrossRefPubMedPubMedCentral
10.
go back to reference Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. Jama 2008;300:2631–7.CrossRefPubMedPubMedCentral Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. Jama 2008;300:2631–7.CrossRefPubMedPubMedCentral
11.
12.
go back to reference Asch DA, Troxel AB, Stewart WF, et al. Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels: A Randomized Clinical Trial. Jama 2015;314:1926–35.CrossRefPubMedPubMedCentral Asch DA, Troxel AB, Stewart WF, et al. Effect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels: A Randomized Clinical Trial. Jama 2015;314:1926–35.CrossRefPubMedPubMedCentral
14.
go back to reference Loewenstein G, Asch DA, Volpp KG. Behavioral economics holds potential to deliver better results for patients, insurers, and employers. Health Aff (Millwood) 2013;32:1244–50.CrossRef Loewenstein G, Asch DA, Volpp KG. Behavioral economics holds potential to deliver better results for patients, insurers, and employers. Health Aff (Millwood) 2013;32:1244–50.CrossRef
15.
go back to reference Kessler JZ, CY. Behavioral Economics and Health. In Oxford Textbook of Public Health, edited by Roger Detels, Martin Guillford, Quarraisha Abdool Karim and Chorh Chuan Tan. Oxford University Press 2015. Kessler JZ, CY. Behavioral Economics and Health. In Oxford Textbook of Public Health, edited by Roger Detels, Martin Guillford, Quarraisha Abdool Karim and Chorh Chuan Tan. Oxford University Press 2015.
16.
go back to reference Choudhry NK, Krumme AA, Ercole PM, et al. Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial. JAMA internal medicine 2017;177:624–31.CrossRefPubMedPubMedCentral Choudhry NK, Krumme AA, Ercole PM, et al. Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial. JAMA internal medicine 2017;177:624–31.CrossRefPubMedPubMedCentral
17.
go back to reference Bobrow, Kristen et al. Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (StAR): A Single Blind Randomized Trail. Circulation 2016; 133:592–600 Bobrow, Kristen et al. Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (StAR): A Single Blind Randomized Trail. Circulation 2016; 133:592–600
18.
go back to reference Nieuwlaat, Richard et al. Interventions for enhancing medication adherence. The Chochrane Database of Systematic Review 2014; 11 Nieuwlaat, Richard et al. Interventions for enhancing medication adherence. The Chochrane Database of Systematic Review 2014; 11
20.
go back to reference Long JA, Jahnle EC, Richardson DM, Loewenstein G, Volpp KG. Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial. Ann Intern Med 2012;156:416–24.CrossRefPubMedPubMedCentral Long JA, Jahnle EC, Richardson DM, Loewenstein G, Volpp KG. Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial. Ann Intern Med 2012;156:416–24.CrossRefPubMedPubMedCentral
21.
go back to reference Reese PP, Kessler JB, Doshi JA, et al. Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes. J Gen Intern Med 2016;31:402–10.CrossRefPubMed Reese PP, Kessler JB, Doshi JA, et al. Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes. J Gen Intern Med 2016;31:402–10.CrossRefPubMed
22.
go back to reference Reddy A, Huseman TL, Canamucio A, et al. Patient and Partner Feedback Reports to Improve Statin Medication Adherence: A Randomized Control Trial. Journal of General Internal Medicine 2017;32:256–61.CrossRefPubMed Reddy A, Huseman TL, Canamucio A, et al. Patient and Partner Feedback Reports to Improve Statin Medication Adherence: A Randomized Control Trial. Journal of General Internal Medicine 2017;32:256–61.CrossRefPubMed
23.
go back to reference Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005;11:449–57.PubMed Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005;11:449–57.PubMed
24.
go back to reference Asch DA, Muller RW, Volpp KG. Automated hovering in health care--watching over the 5000 hours. N Engl J Med 2012;367:1–3.CrossRefPubMed Asch DA, Muller RW, Volpp KG. Automated hovering in health care--watching over the 5000 hours. N Engl J Med 2012;367:1–3.CrossRefPubMed
25.
go back to reference Crawford JR, Henry JD, Ward AL, Blake J. The Prospective and Retrospective Memory Questionnaire (PRMQ): latent structure, normative data and discrepancy analysis for proxy-ratings. The British journal of clinical psychology 2006;45:83–104.CrossRefPubMed Crawford JR, Henry JD, Ward AL, Blake J. The Prospective and Retrospective Memory Questionnaire (PRMQ): latent structure, normative data and discrepancy analysis for proxy-ratings. The British journal of clinical psychology 2006;45:83–104.CrossRefPubMed
26.
go back to reference Smith G, Della Sala S, Logie RH, Maylor EA. Prospective and retrospective memory in normal ageing and dementia: a questionnaire study. Memory 2000;8:311–21.CrossRefPubMed Smith G, Della Sala S, Logie RH, Maylor EA. Prospective and retrospective memory in normal ageing and dementia: a questionnaire study. Memory 2000;8:311–21.CrossRefPubMed
27.
go back to reference Weber Elke, Ann Renee Blais, and Nancy E Betz. A Domain-specific Risk-attitude Scale: Measuring Rish Perceptions and Risk Behaviors. Journal of Behavioral Decision Making 2002;15:263–90.CrossRef Weber Elke, Ann Renee Blais, and Nancy E Betz. A Domain-specific Risk-attitude Scale: Measuring Rish Perceptions and Risk Behaviors. Journal of Behavioral Decision Making 2002;15:263–90.CrossRef
28.
go back to reference Blais Ann Renee, and Elke U Weber. A Domain-Specific Risk-Taking (DOSPERT) scale for adult populations. Jounal of Judgement and Decision Making 2006;1:33–47. Blais Ann Renee, and Elke U Weber. A Domain-Specific Risk-Taking (DOSPERT) scale for adult populations. Jounal of Judgement and Decision Making 2006;1:33–47.
29.
go back to reference Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc 2012;19:696–704.CrossRefPubMedPubMedCentral Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc 2012;19:696–704.CrossRefPubMedPubMedCentral
30.
go back to reference Lantz PM, Stencil D, Lippert MT, Beversdorf S, Jaros L, Remington PL. Breast and cervical cancer screening in a low-income managed care sample: the efficacy of physician letters and phone calls. Am J Public Health 1995;85:834–6.CrossRefPubMedPubMedCentral Lantz PM, Stencil D, Lippert MT, Beversdorf S, Jaros L, Remington PL. Breast and cervical cancer screening in a low-income managed care sample: the efficacy of physician letters and phone calls. Am J Public Health 1995;85:834–6.CrossRefPubMedPubMedCentral
31.
go back to reference Rodgers A, Corbett T, Bramley D, et al. Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob Control 2005;14:255–61.CrossRefPubMedPubMedCentral Rodgers A, Corbett T, Bramley D, et al. Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob Control 2005;14:255–61.CrossRefPubMedPubMedCentral
32.
go back to reference Cadena Ximena, and Antoinette Schoar. Remembering to Pay? Reminders vs. Fianancial Incentives for Loan Payments. NBER Working Paper Series 2011;NBER working paper no: 17020. Cadena Ximena, and Antoinette Schoar. Remembering to Pay? Reminders vs. Fianancial Incentives for Loan Payments. NBER Working Paper Series 2011;NBER working paper no: 17020.
33.
go back to reference Karlan D, Mcconnel M, Mullainathan S, and Zinman J. Getting to the top of mind: How reminders increase savings. Management Science 2016, forthcoming. Karlan D, Mcconnel M, Mullainathan S, and Zinman J. Getting to the top of mind: How reminders increase savings. Management Science 2016, forthcoming.
34.
go back to reference Cadena X, Schoar A, Cristea A, and Delgado-Medrano HM. Fighting procratination in the workplace: and experiment. NBER Working Paper Series 2011;NBER working paper 16944. Cadena X, Schoar A, Cristea A, and Delgado-Medrano HM. Fighting procratination in the workplace: and experiment. NBER Working Paper Series 2011;NBER working paper 16944.
Metadata
Title
Partners and Alerts in Medication Adherence: A Randomized Clinical Trial
Authors
Judd B. Kessler, PhD
Andrea B. Troxel, ScD
David A. Asch, MD, MBA
Shivan J. Mehta, MD, MBA, MSHP
Noora Marcus, MA
Raymond Lim, MA
Jingsan Zhu, MS, MBA
William Shrank, MD, MSHS
Troyen Brennan, MD
Kevin G. Volpp, MD, PhD
Publication date
01-09-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 9/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4389-7

Other articles of this Issue 9/2018

Journal of General Internal Medicine 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.